project id: TCGA-BLCA; case submitter id: TCGA-H4-A2HQ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.1; age at index: 64; days to birth: -23538; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1946; age at diagnosis: 23538; ajcc clinical t: T2b; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 590.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; cigarettes per day: 0.3835616438356164; pack years smoked: 7.0; is ffpe: false; composition: Not Reported; days to collection: 200; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-H4-A2HQ-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 7.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 18.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;